7 results match your criteria: "MICOER-Institute[Affiliation]"
Infect Genet Evol
April 2019
Medical University of Sofia, Medical Faculty, Department of Medical Microbiology, Bulgaria.
Aim: The aim of this study was to investigate the mechanisms of beta-lactam-resistance and the clonal relatedness of carbapenem-nonsusceptible Klebsiella pneumoniae and Escherichia coli isolates, collected consecutively in eight centers in five Bulgarian cities from November 2014 to March 2018. Carbapenemase-producing enterobacteria were detected in all but one centers. Overall, 104 K.
View Article and Find Full Text PDFMicrob Drug Resist
April 2017
1 Department of Medical Microbiology, Medical Faculty, Medical University Sofia, Sofia, Bulgaria .
The aim of this study was to analyze the beta-lactamases and the molecular epidemiology of 19 clinically significant isolates of Proteus mirabilis with decreased susceptibility to imipenem, which have been collected from seven hospitals, located in different Bulgarian towns (Sofia, Varna, and Pleven). The isolates were obtained from blood, urine, tracheal and wound specimens. One additional isolate from hospital environment was included.
View Article and Find Full Text PDFAntimicrob Agents Chemother
November 2015
MICOER Institute, Munich, Germany.
We analyzed the oxacillinases of isolates of six different species of Pandoraea, a genus that colonizes the respiratory tract of cystic fibrosis patients. The isolates produced carbapenem-hydrolyzing enzymes causing elevated MICs for amoxicillin, piperacillin, meropenem, and imipenem when expressed in an Escherichia coli host strain. Sequencing revealed nine new oxacillinases (OXA-151 to OXA-159) with a high degree of identity among isolates of the same species; however, they had much lower interspecies similarities.
View Article and Find Full Text PDFAntimicrob Agents Chemother
October 2009
MICOER Institute, Munich, Germany.
A single Klebsiella pneumoniae strain isolated in a Bulgarian hospital was found to produce CTX-M-71, a new CTX-M variant characterized by one amino acid substitution from glycine to cysteine at position 238 in comparison to CTX-M-15. This exchange decreased the hydrolytic activity of the beta-lactamase for cefotaxime, ceftazidime, and cefepime.
View Article and Find Full Text PDFAntimicrob Agents Chemother
August 2008
MICOER-Institute, Hesseloherstrasse 4, 80802 Munich, Germany.
Two Pseudomonas aeruginosa urine isolates from Bulgaria and Germany produced two new VIM-2 variants. VIM-15 had one amino acid substitution (Tyr218Phe) which caused a significant increase in hydrolytic efficiency. The substitution Ser54Leu, characterizing VIM-16, showed no influence on enzyme activity.
View Article and Find Full Text PDFInt J Antimicrob Agents
June 2007
MICOER Institute, Hesseloherstrasse 4, 80802 Munich, Germany.
During a survey of extended-spectrum beta-lactamases (ESBLs) in Bulgaria from 1996 to 2003, a TEM-3-like ESBL was detected in strains of Klebsiella pneumoniae, Escherichia coli, Citrobacter freundii and Klebsiella oxytoca from three centres in three different towns. The nucleotide sequence of the cloned gene was identical to that of TEM-3, except for one substitution (C347A) causing an amino acid exchange at position 49 from leucine to methionine. This TEM-3 variant with both a unique nucleotide and amino acid sequence was designated TEM-139.
View Article and Find Full Text PDFAntimicrob Agents Chemother
April 2006
MICOER Institute, Hesseloherstrasse 4, 80802 Munich, Germany.
Pandoraea spp. are gram-negative, glucose nonfermenting rods detectable in blood cultures and sputa of cystic fibrosis patients. They are resistant to various antibiotic groups, with imipenem being the only active beta-lactam.
View Article and Find Full Text PDF